Cardiac shock wave therapy improves angina symptoms

March 30, 2012
Cardiac shock wave therapy improves angina symptoms

(HealthDay) -- Cardiac shock wave therapy (CSWT) can significantly improve symptoms, ischemic threshold during exercise, and specific quality-of-life parameters for patients with chronic refractory angina pectoris, according to a study published online March 23 in Cardiovascular Therapeutics.

To investigate whether CSWT can relieve the symptoms of chronic refractory angina pectoris, Jean-Paul Schmid, M.D., of the Bern University Hospital in Switzerland, and colleagues conducted a prospective, randomized, placebo-controlled study involving 21 patients with chronic refractory angina pectoris and evidence of inducible myocardial ischemia during MIBI single-photon emission computed tomography imaging. Eleven patients received nine sessions of CSWT (200 shots/spot, energy intensity of 0.09 mJ/mm²) over three months, and 10 controls received an acoustic simulation without energy application.

The researchers found that nine of 11 CSWT-treated patients experienced statistically significant symptom improvement, measured by cardiopulmonary stress testing, compared with two of 10 placebo-treated patients. Physical functioning, general health perception, and vitality items on the Short Form-36 questionnaire were significantly improved in CSWT-treated patients, compared with no improvement in placebo-treated patients.

"This prospective, randomized study shows that CWST reduces clinical symptoms and objective signs of . CSWT therefore emerges as a new non-invasive technique for treatment of refractory angina pectoris in patients with advanced coronary artery disease," the authors write.

Explore further: Stem cell injections may offer hope to patients with no other options

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Stem cell injections may offer hope to patients with no other options

July 7, 2011
An injection of stem cells into the heart could offer hope to many of the 850,000 Americans whose chest pain doesn't subside even with medicine, angioplasty or surgery, according to a study in Circulation Research: Journal ...

Recommended for you

Research suggests new pathways for hyperaldosteronism

December 7, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), in collaboration with researchers at Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the ...

One-dose gene therapy produces clotting factor, safely stops bleeding in hemophilia B patients

December 6, 2017
A team of gene therapy researchers has reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B. A single intravenous infusion of a novel bioengineered gene therapy treatment ...

Clot-busting drugs not recommended for most patients with blood clots

December 6, 2017
Not all patients with blood clots in their legs - a condition known as deep vein thrombosis - need to receive powerful but risky clot-busting drugs, according to results of a large-scale, multicenter clinical trial.

Mitochondrial protein in cardiac muscle cells linked to heart failure, study finds

December 5, 2017
Reducing a protein found in the mitochondria of cardiac muscle cells initiates cardiac dysfunction and heart failure, a finding that could provide insight for new treatments for cardiovascular diseases, a study led by Georgia ...

Blood pressure declines 14 to 18 years before death

December 4, 2017
Blood pressure in the elderly gradually begins to decrease about 14 or so years before death, according to a new study published today in the JAMA Internal Medicine.

Study links common male medical condition and vascular disease

December 1, 2017
Men who suffer symptoms from varicoceles, enlarged veins in the scrotum, are more likely to develop vascular disease and metabolic disease, such as diabetes, according to a study by Stanford University School of Medicine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.